QuantaLife, Inc. Employee Directory
Biotechnology ResearchCalifornia, United States11-50 Employees
QuantaLife, Inc. developed Droplet Digital PCR, a method that provides absolute quantification of target molecules with high resolution and sensitivity. Its applications include copy number variation analysis, mutation detection, and gene expression studies. The company aimed to furnish tools that can accelerate diagnosis and treatment for inherited disorders, cancer, and infectious disease. The technology is now part of Bio-Rad Laboratories as the QX100 Droplet Digital PCR System, with QuantaLife’s former site in Pleasanton, California continuing to host development at Bio-Rad’s Digital Biology Center. Based in the biotechnology research field, QuantaLife is a small to mid-sized firm whose core technology has been integrated into Bio-Rad, a global leader in life science research and clinical diagnostics. The Digital Biology Center in Pleasanton remains a hub for ongoing refinement of ddPCR, supporting researchers addressing inherited disorders, cancer, and infectious disease. This arrangement situates QuantaLife’s innovations within a larger corporate ecosystem while preserving the focus on precise molecular quantification.